Have to agree there. The refurbished Medivet website is quite professional, I like the timeline of activities and pipeline of future release diagrams, it encourages further page views.
Medaust.com is ok for its purpose, but they could probably sell the business and activities slightly better. As things improve it would be nice to see the occasional intra quarter update. Although I'm happy management spend the vast bulk of their time drumming up business, a bit of SP support in the form of a presentation or updated metrics and chunky sales contracts, couldn't hurt.
The overall website hits are probably reflective of the relatively stable share register and the poor liquidity. My bet would be that as soon as the business creeps into the black it will flag on many more investor’s radars, i.e. those who scan the asx company list for low PEs, favourable P/S ratios & profitable sub 10m market caps, leading to more website hits and turnover. Until this happens I think MLA will fly under the radar.
I see a couple ~400k parcels have appeared on the sell-side the past couple days since the release from escrow. So will be interesting to see if it's Medivet holders? Might look to buy myself another parcel for christmas!
All DYOR, IMO etc…
MLA Price at posting:
5.4¢ Sentiment: Buy Disclosure: Held
